Abstract :

Background: Tuberculosis and diabetes mellitus are major public health problems with a well-recognized bidirectional relationship. Diabetes mellitus increases the risk of active tuberculosis, while tuberculosis may worsen glycemic control. This comorbidity may also increase household economic burden through higher non-medical expenses, productivity loss, and catastrophic health expenditure. Evidence comparing the economic burden of tuberculosis patients with and without diabetes mellitus in Kupang City remains limited.

Objective: To compare the economic burden between tuberculosis patients without diabetes mellitus and tuberculosis patients with diabetes mellitus in Kupang City, Indonesia, in 2025.

Methods: This comparative cross-sectional study included 86 respondents, consisting of 43 tuberculosis patients without diabetes mellitus and 43 tuberculosis patients with diabetes mellitus who were receiving outpatient treatment at 10 primary health centers in Kupang City.

Results: A significant difference in economic burden was observed between the two groups. The median total cost among tuberculosis patients without diabetes mellitus was IDR 255,000, whereas the median total cost among tuberculosis patients with diabetes mellitus was IDR 850,000. Direct non-medical costs and indirect costs were also higher in the tuberculosis-diabetes mellitus group. Catastrophic costs were significantly more frequent in the TB-DM group than in the TB non-DM group (44.2% vs. 20.9%; p = 0.021).

Conclusion: Diabetes mellitus significantly increases the economic burden among tuberculosis patients. Compared with tuberculosis patients without diabetes mellitus, those with tuberculosis and diabetes mellitus incur higher total costs, greater non-medical expenditures, and higher indirect costs. These findings support the need for integrated tuberculosis-diabetes services and stronger financial protection strategies for vulnerable patients.

---

Keywords :

Catastrophic Health Expenditure, Comorbidity, diabetes mellitus, Economic Burden, Indonesia, Tuberculosis

---

References :

1. World Health Organization. Global tuberculosis report 2025. Geneva: World Health Organization; 2025.
2. World Health Organization Indonesia. Indonesia charts next phase of TB response through national programme review. Jakarta: WHO Indonesia; 2026.
3. Muharram FR, Swannjo JB, Melbiarta RR, Martini S. Trends of diabetes and pre-diabetes in Indonesia 2013–2023: a serial analysis of national health surveys. BMJ Open. 2025;15(9):e098575.
4. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152.
5. Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis. PLoS One. 2017;12(11):e0187967.
6. World Health Organization. Consolidated guidance on tuberculosis data generation and use: module 4: surveys of costs faced by households affected by tuberculosis. Geneva: World Health Organization; 2025.
7. Rupani MP, Vyas S. A sequential explanatory mixed-methods study on costs incurred by patients with tuberculosis comorbid with diabetes in Bhavnagar, western India. Sci Rep. 2023;13(1):150.
8. Yamanaka T, Castro MC, Ferrer JP, Solon JA, Cox SE, Laurence YV, et al. Costs incurred by people with co-morbid tuberculosis and diabetes and their households in the Philippines. PLoS One. 2024;19(1):e0297342.
9. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lonnroth K, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9:81.
10. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9(12):737-46.
11. Restrepo BI. Diabetes and tuberculosis. Microbiol Spectr. 2016;4(6):TNMI7-0023-2016.
12. Tanimura T, Jaramillo E, Weil D, Raviglione M, Lonnroth K. Financial burden for tuberculosis patients: a systematic review. Eur Respir J. 2014;43(6):1763-75.
13. Wingfield T, Boccia D, Tovar MA, Huff D, Montoya R, Ramos E, et al. Defining catastrophic costs and comparing their importance for tuberculosis patients. PLoS Med. 2014;11(7):e1001675.
14. Fuady A, Houweling TAJ, Mansyur M, Richardus JH. Catastrophic total costs in tuberculosis-affected households in Indonesia. Infect Dis Poverty. 2018;7(1):3.
15. Fuady A, Houweling TAJ, Mansyur M, Burhan E, Richardus JH. Catastrophic costs due to tuberculosis worsen treatment outcomes. Trans R Soc Trop Med Hyg. 2020;114(9):666-73.
16. de Andrade KVF, Nery JS, de Souza RA, Pereira SM. Effects of social protection on tuberculosis treatment outcomes: a systematic review and meta-analysis. Cad Saude Publica. 2018;34(1):e00153116.
17. Rupani MP, Vyas S. A sequential explanatory mixed-methods study on costs incurred by patients with tuberculosis comorbid with diabetes in Bhavnagar, western India. Sci Rep. 2023;13(1):150.
18. Yamanaka T, Castro MC, Ferrer JP, Solon JA, Cox SE, Laurence YV, et al. Costs incurred by people with co-morbid tuberculosis and diabetes in the Philippines. PLoS One. 2024;19(1):e0297342.
19. Lonnroth K, Roglic G, Harries AD. Improving tuberculosis prevention and care through addressing diabetes. Int J Tuberc Lung Dis. 2014;18(7):721-7.
20. Harries AD, Satyanarayana S, Kumar AMV, Nagaraja SB, Isaakidis P, Malhotra S, et al. Epidemiology and interaction of diabetes mellitus and tuberculosis. Public Health Action. 2013;3 Suppl 1:S3-9.
21. World Health Organization. Collaborative framework for care and control of tuberculosis and diabetes. Geneva: World Health Organization; 2011.
22. World Health Organization, International Labour Organization. Guidance on social protection for people affected by tuberculosis. Geneva: World Health Organization; 2024.
23. Fuady A, Hutanamon T, Herlinda O, Burhan E, Houweling TAJ, Vassall A. Achieving universal social protection for people with tuberculosis. Lancet Public Health. 2024;9:e339-44.
24. Armstrong LR, Kammerer JS, Haddad MB. Diabetes mellitus among adults with tuberculosis in the USA, 2010–2017. BMJ Open Diabetes Res Care. 2020;8(1):e001275.
25. Boccia D, Hargreaves J, De Stavola BL, Fielding K, Schaap A, Godfrey-Faussett P, et al. The association between household socioeconomic position and tuberculosis prevalence. PLoS One. 2011;6(6):e20824.
26. Barter DM, Agboola SO, Murray MB, Barnighausen T. Tuberculosis and poverty: a systematic review. BMC Public Health. 2012;12:980.
27. Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics. Soc Sci Med. 2009;68(12):2240-6.
28. World Health Organization. The End TB Strategy. Geneva: World Health Organization; 2015.
29. Lonnroth K, Raviglione M. The WHO End TB Strategy in the era of SDGs. Trans R Soc Trop Med Hyg. 2016;110(3):148-50.
30. van den Hof S, Collins D, Hafidz F, Beyene D, Tursynbayeva A, Tiemersma EW. The socioeconomic impact of multidrug-resistant tuberculosis. BMC Infect Dis. 2016;16:470.